• Home
  • News
  • UCI statement On Luca Paolini

UCI statement On Luca Paolini

UCI Logo

This article is written in English with a French translation underneath.

The Union Cycliste Internationale (UCI) announces that it has notified Italian rider Luca Paolini of an Adverse Analytical Finding of Cocaine (Benzoylecgonine metabolite) in a sample collected in the scope of an in-competition control on 7 July 2015 during the Tour de France.

The rider has the right to request and attend the analysis of the B sample.

In accordance with UCI Anti-doping Rules, the rider has been provisionally suspended until the adjudication of the affair.

At this stage of the procedure, the UCI will not comment any further.

Déclaration de l’UCI au sujet de Luca Paolini

L’Union Cycliste Internationale (UCI) annonce qu’elle a notifié le coureur italien Luca Paolini d’un résultat d’analyse anormal (présence de cocaïne – métabolite de benzoylecgonine) dans un échantillon collecté à l’occasion d’un contrôle en compétition, le 7 juillet 2015 lors du Tour de France.

Le coureur a le droit de demander l’analyse de l’échantillon B et d’y assister.

Conformément au Règlement antidopage de l’UCI, ce dernier a été suspendu provisoirement et ce jusqu’à la résolution de l’affaire.

L’UCI ne fera pas d’autres commentaires à ce stade de la procédure.

Leave a comment

Please login to leave a comment.


Legal Advisors

Copyright © LawInSport Limited 2010 - 2022. These pages contain general information only. Nothing in these pages constitutes legal advice. You should consult a suitably qualified lawyer on any specific legal problem or matter. The information provided here was accurate as of the day it was posted; however, the law may have changed since that date. This information is not intended to be, and should not be used as, a substitute for taking legal advice in any specific situation. LawInSport is not responsible for any actions taken or not taken on the basis of this information. Please refer to the full terms and conditions on our website.